US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Braveheart Bio

27.18

+0.90003.42%

Volume:154.20K

Turnover:4.10M

Market Cap:1.92B

PE:-23.93

High:27.46

Open:26.53

Low:25.73

Close:26.28

52wk High:32.00

52wk Low:24.31

Shares:70.65M

Float Shares:18.75M

Volume Ratio:0.77

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1360

EPS(LYR):-3.9270

ROE:--

ROA:--

PB:-24.50

PE(LYR):-6.92

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Braveheart Bio Initiated at Buy by Stifel

Cantor Fitzgerald Initiates Braveheart Bio at Overweight With $40 Price Target

MT Newswires Live

Stifel Initiates Braveheart Bio at Buy With $45 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BRVE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BRVE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","market":"US","secType":"STK","nameCN":"Braveheart Bio","latestPrice":27.18,"timestamp":1788369860773,"preClose":26.28,"halted":0,"volume":154196,"delay":0,"changeRate":0.034246575342465696,"floatShares":18750000,"shares":70652838,"eps":-1.136,"marketStatus":"Trading","change":0.9,"latestTime":"09-02 13:24:39 EDT","open":26.53,"high":27.4625,"low":25.73,"amount":4099874.577512,"amplitude":0.065925,"askPrice":27.22,"askSize":143,"bidPrice":26.79,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.136,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1785988800000,"exchange":"NASDAQ","adjPreClose":26.28,"preHourTrading":{"tag":"盘前","latestPrice":27.09,"preClose":26.28,"latestTime":"09:28 EDT","volume":109,"amount":2902.960158,"timestamp":1788355680076,"change":0.81,"changeRate":0.030822,"amplitude":0.028158},"postHourTrading":{"tag":"盘后","latestPrice":26.28,"preClose":26.28,"latestTime":"19:30 EDT","volume":9,"amount":236.52,"timestamp":1788305405930,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.773301},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","floatShares":18750000,"roa":"--","roe":"--","lyrEps":-3.927011,"volumeRatio":0.773301,"shares":70652838,"dividePrice":0,"high":27.4625,"amplitude":0.065925,"preClose":26.28,"low":25.73,"week52Low":24.305,"pbRate":"-24.50","week52High":32,"institutionHeld":0,"latestPrice":27.18,"committee":-0.481865,"eps":-1.136,"divideRate":0,"volume":154196,"delay":0,"ttmEps":-1.136,"open":26.53,"prevYearClose":18,"prevWeekClose":27.44,"prevMonthClose":25.5,"prevQuarterClose":18,"fiveDayClose":27.76,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRVE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRVE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRVE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BRVE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BRVE","date":"2026-09-01","current":-23.926056,"percent":0.842105,"low":-23.993466,"twenty":-22.21795,"median":-21.970016,"eighty":-20.695164,"high":-12.297967,"avg":-20.997657,"sd":2.799907,"marketCap":1636307587},"quantilePoints":[{"date":"2026-08-07","current":-22.904964,"twenty":-19.277064,"median":-13.835213,"eighty":-12.912865,"marketCap":1837733965},{"date":"2026-08-14","current":-20.770344,"twenty":-22.55018,"median":-20.842324,"eighty":-16.302149,"marketCap":1666466982},{"date":"2026-08-21","current":-21.930028,"twenty":-22.591769,"median":-21.618113,"eighty":-20.309669,"marketCap":1759511923},{"date":"2026-08-28","current":-22.281932,"twenty":-22.249941,"median":-22.006007,"eighty":-20.827928,"marketCap":1787746250},{"date":"2026-09-01","current":-20.394446,"twenty":-22.21795,"median":-21.970016,"eighty":-20.695164,"marketCap":1636307587}],"updateTime":1788369879487},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRVE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664086926","title":"Braveheart Bio to Participate in Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664086926","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664086926?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:30","pubTimestamp":1788294600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354630/0/en/braveheart-bio-to-participate-in-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU0029874061.USD","BK4567","BK4137","LU0069063385.USD","HCSG","XLV","BK4531","LU0289739343.SGD","MADE","LU0124676726.USD","IE000M9KFDE8.USD","BK4533","BK4149","BRVE","CMI","LU0154245673.USD","LU2463526074.USD","HCM","LU0057025933.USD","LU0128526141.USD","LU0154245756.USD","BK4585","LU0203347892.USD","LU0289961442.SGD","LABU","BK4588","LU0203345920.USD","LU0472753341.HKD","BK4007","LU0689626769.HKD","LU0511384066.AUD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072364","title":"Braveheart Bio Initiated at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663072364?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:36","pubTimestamp":1788172560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BRVE/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663224074","title":"Cantor Fitzgerald Initiates Braveheart Bio at Overweight With $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2663224074","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663224074?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:32","pubTimestamp":1788172345,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald Initiates Braveheart Bio at Overweight With $40 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663718150","title":"Stifel Initiates Braveheart Bio at Buy With $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2663718150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663718150?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:49","pubTimestamp":1788169786,"startTime":"0","endTime":"0","summary":"Stifel Initiates Braveheart Bio at Buy With $45 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BRVE\",params:#limit:6,delay:false,,,undefined,":[]}}